SEC

After ALS trial misses mark, Seelos has filed for bankruptcy
Fierce Biotech
Sun, 11/24/24 - 05:55 pm
Seelos Therapeutics
ALS
bankruptcy
SEC
Pfizer loses bid to recoup $75 million left over from SEC settlement
MSN/Reuters
Tue, 11/19/24 - 07:19 pm
Pfizer
legal
SEC
insider trading
Cassava’s Alzheimer’s drug nears P3 readout, but SEC scandal casts long shadow R&D
Pharmaphorum
Wed, 11/6/24 - 11:35 am
Cassava Biosciences
Alzheimer's disease
SEC
clinical trials
simufilam
Cassava Sciences: Phase III trials storm ahead amid controversy
Clinical Trials Arena
Wed, 10/9/24 - 09:56 am
Cassave Sciences
clinical trials
simufilam
SEC
Cassava, former execs ink SEC deal to resolve allegations around misleading Alzheimer's data drop
Fierce Biotech
Mon, 09/30/24 - 09:23 am
Cassava Sciences
Alzheimer's disease
SEC
SEC Hits Allarity With Wells Notice, Flags Alleged Violations in FDA Meeting
BioSpace
Tue, 07/23/24 - 11:32 am
Allarity Therapeutics
SEC
FDA
securities law
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy
BioSpace
Fri, 04/5/24 - 11:52 am
Novo Nordisk
M&A
Catalent
SEC
BioMarin Hit with DOJ Subpoena on Sponsored Testing for Rare Diseases
BioSpace
Tue, 02/27/24 - 11:31 am
Biomarin
SEC
DOJ
Vimizim
Naglazyme
Catalent delays quarterly filing with SEC on $700 mln impairment charge
Reuters
Tue, 11/14/23 - 11:18 am
Catalent
SEC
M&A
SEC Investigating Illumina’s Multi-Billion Dollar Merger with GRAIL
BioSpace
Fri, 08/11/23 - 11:40 am
SEC
Illumina
Grail
M&A
cancer
diagnostics
Former Merck VP Nirdosh Jagota settles with SEC on insider trading charge
Fierce Pharma
Thu, 07/20/23 - 09:58 am
Merck
Pandion Therapeutics
SEC
insider trading
BioXCell’s potential episodic Alzheimer’s agitation treatment marred by missed trial protocols, fabricated emails and failed endpoint
Fierce Pharma
Thu, 06/29/23 - 11:42 am
BioXCell
Alzheimer's disease
Alzheimer's agitation
dexmedetomidine
SEC
Philips will pay more than $62M to settle SEC corruption charges
Medtech Dive
Fri, 05/12/23 - 11:32 am
Philips
Medtech
SEC
FCPA
China
legal
Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit
Fierce Pharma
Tue, 03/28/23 - 10:57 pm
Esperion Therapeutics
Daiichi Sankyo
Nexletol
SEC
SEC says Eli Lilly can't avoid requests for more info on diversity efforts, abortion stance
Endpoints
Thu, 03/16/23 - 07:00 pm
Eli Lilly
SEC
abortion
diversity
DEI
Indiana
Viatris executive charged in insider trading scheme that allegedly netted $7.2 million
Fierce Pharma
Sun, 11/13/22 - 06:55 pm
Viatris
insider trading
SEC
Zymergen Cuts 80 More Jobs, Parts Ways with Co-Founder
BioSpace
Fri, 08/26/22 - 10:39 am
Zymergen
SEC
layoffs
AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program
Endpoints
Tue, 08/16/22 - 11:59 pm
AbbVie
CD47
SEC
clinical trials
I-Mab
Zai Lab
For accounting purposes, Biogen says its $223M inventory of Aduhelm is basically worthless
Endpoints
Thu, 07/21/22 - 09:47 pm
Biogen
Aduhelm
Alzheimer's disease
SEC
Epizyme SEC filing details its desperate days in free fall before $247M sale to Ipsen
Fierce Pharma
Wed, 07/13/22 - 10:09 am
Epizyme
SEC
M&A
Ipsen

Pages